Please use this identifier to cite or link to this item:
|Title in Portuguese:||Evaluation of synergistic effect of kaurenoic acid derivatives with fluconazole a gainst strains of fluconazole-resistant Candida parapsilosis|
|Author:||Andrade Neto, João Batista de|
Silva, Cecília Rocha da
Campos, Rosana de Sousa
Nascimento, Francisca B. S. A.
Sampaio, Letícia Serpa
Silva, Anderson R. da
Silva, Rose A.C.
Freitas, Daniel D. de
Josino, Maria Aparecida
Andrade, Larissa N.D. de
Magalhães, Hemerson Iury Ferreira
Gaspar, Danielle Macedo
Moraes Filho, Manoel Odorico de
Silveira, Edilberto R.
Gomes, Akenaton Onassis Cardoso Viana
Câmara, Claudio A.G.
Lima, Iri Sandro Pampolha
Cavalcanti, Bruno Coêlho
Nobre Júnior, Hélio Vitoriano
|Publisher:||International Journal of Current Microbiology and Applied Sciences|
|Citation:||ANDRADE NETO, J. B. de et al. Evaluation of synergistic effect of kaurenoic acid derivatives with fluconazole against strains of fluconazole-resistant Candida parapsilosis. International Journal of Current Microbiology and Applied Sciences, v. 4, n. 5, p. 68-79, may. 2015.|
|Abstract:||Candida species are the fourth most common cause of nosocomial bloodstream infections in the United States and the fifth to tenth most common causative pathogen in European studies Although C. albicans remains the most common fungal isolate recovered from blood, recent reports indicate a trend towards an increasing prevalence of infections caused by species of Candida other than C. albicans which are associated with a highly mortality rate. Furthermore, antifungal drug resistance (i.e. resistance to azole compounds) is a prominent feature in the management of invasive mycoses, and its epidemiological characteristics continue to evolve. This scenario leads to seek for new candidates for antifungal drugs able to overcome the resistance issues of Candida species. Kaurenoic acid (KA) or ent-kaur-16-en-19-oic acid is a tetracyclic diterpene present in several plants known to exert several pharmacological activities such cytotoxic actions and antimicrobial in vitro. The aim of current study was evaluate the potential antifungal of the natural diterpenoids kauren-19-oic acid (KA), 14-hydroxy-kaurane (1) and xylopic acid (2), and semi-synthetic derivatives of KA (3-5) towards Candida parapsilosis. Six combinations formed by different diterpenoids kauren-19-oic acid (KA), compounds (1-5), were tested using varied fluconazole concentration. We concluded that the compound 4 (16 -methoxy-( )-kauran-19-oic methylester) when combined with fluconazole, show activity against strains of C. parapsilosis resistant to fluconazole.|
|metadata.dc.type:||Artigo de Periódico|
|Appears in Collections:||PPGF - Artigos publicados em revistas científica|
Files in This Item:
|2015_art_jbandradeneto.pdf||420,8 kB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.